Back to trial details

Intake questionnaire

Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC

Applying to VA Palo Alto Health Care System, Palo Alto, CA · Palo Alto, California

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Relapsed Small Cell Lung Cancer?
3. Are you able to travel to Palo Alto for study visits?